Cardiology


The Effect of Concomitant Treatment with Aspirin and Famotidine on Platelet Function in Humans

Investigator: Granada, Juan
Phone Number: (713) 383-3575


24 Month, Multicenter, Randomized, Open-Label Non-Inferiority Study of Efficacy and Safety Comparing Two Exposures of Concentration-Controlled Certican With Reduced Neoral Versus 3.0g MMF With Standard Dose Neoral In De Novo Heart Transplant Recipients

Investigator: Guillermo, Torre-Amione
Phone Number: (713) 441-3575


A Clinical Trial Comparing Cangrelor to Clopidogrel in Subjects with Acute Coronary Syndromes who are to be Managed with Percutaneous Coronary Intervention (CHAMPION-PCI)

Investigator: Kleiman, Neal
Phone Number: (713) 441-3910


A multi-center dose-ranging study of the REG1 Anticoagulation System to determine the pharmacokinetics, pharmacodynamics, safety profile, and biochemical marker relationships in subjects with stable coronary artery disease on oral antiplatelet therapy

Investigator: Kleiman, Neal
Phone Number: (713) 441-3910


Protocol H7T-MC-TABM A Pharmacodynamic Comparison of Prasugrel (LY640315) versus Clopigrel in Subjects with Acute Coronary Syndrome Who Have Recently Undergone Percutaneous Coronary Intervention and Are Receiving Clopigerl (S.W.A.P. - Switching Anti Plate

Investigator: Kleiman, Neal
Phone Number: (713) 441-3910


The Effect of Caffeine on the Response to Clopidogrel in Stable Patients with Coronary Artery Disease

Investigator: Kleiman, Neal
Phone Number: (713) 383-3910


A Phase 2 Randomized, Double-Blind, Placebo-Controlled Exploratory Efficacy Study of Sitaxsentan Sodium to Improve Impaired Exercise Tolerance in Subjects with Diastolic Heart Failure

Investigator: Kurrelmeyer, Karla
Phone Number: (713) 441-3575


Development of a Normal Database and Criteria for Abnormality for Beta-methyl-p-[123I]-Iodophenyl-pentadecanoic acid (Iodofiltic acid I-123) for Quantitative Imaging

Investigator: Mahmarian, John
Phone Number: (713) 441-2849


Resyncronization Reverses Remodelnig in Systolic Left Ventricular Dysfunction (REVERSE)

Investigator: Nasir, Nadim
Phone Number: (713) 791-1978


RETHINQ (Resynchronization Therapy in Narrow QRS)

Investigator: Nasir, Nadim
Phone Number: 713) 791-1978


TRENDS Study

Investigator: Nasir, Nadim
Phone Number: (713) 791-1978


Victory IDE Clinical Study

Investigator: Nasir, Nadim
Phone Number: (713) 791-1978


A Multicenter, Non-Randomized Study of the 2.25 mm Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Patients with the DeNovo Coronary Artery Lesions Sirus 2.25 MM Protocol P03-6320 Amend. 3 Dated January 8, 2004 - The Sirius 2.25

Investigator: Raizner, Albert
Phone Number: (713) 441-4123


Future Revascualrization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease- The Freedom Trial

Investigator: Raizner, Albert
Phone Number: (713) 441-4123


Rhythm ID Going Head-to-Head Trial

Investigator: Rami, Tapan
Phone Number: (713) 383-5161


The role of contractile dysfunction in post heart transplant rejection

Investigator: Torre-Amione, Guillermo
Phone Number: (713) 383-3575


Evaluation of the ZilverR PTX-TM Vascular Stent in the Above-the-Knee Femoropopliteal Artery

Investigator: Walton, Brian
Phone Number: (713) 441-4123



 
Back to Top